Indirect burden of diabetes in the U.S., 2017 (in billions of dollars)
| Cost component . | Productivity loss . | Total cost attributable to diabetes ($) . | Proportion of indirect costs* . |
|---|---|---|---|
| Work days absent | 14 million days | 3.3 | 3.7% |
| Reduced performance at work | 114 million days | 26.9 | 29.7% |
| Reduced productivity days for those not in labor force | 14 million days | 2.3 | 2.6% |
| Reduced labor force participation due to disability | 182 million days | 37.5 | 41.7% |
| Mortality | 277,000 deaths | 19.9 | 22.1% |
| Total | 89.9 | 100% |
| Cost component . | Productivity loss . | Total cost attributable to diabetes ($) . | Proportion of indirect costs* . |
|---|---|---|---|
| Work days absent | 14 million days | 3.3 | 3.7% |
| Reduced performance at work | 114 million days | 26.9 | 29.7% |
| Reduced productivity days for those not in labor force | 14 million days | 2.3 | 2.6% |
| Reduced labor force participation due to disability | 182 million days | 37.5 | 41.7% |
| Mortality | 277,000 deaths | 19.9 | 22.1% |
| Total | 89.9 | 100% |
Data source: analysis of the NHIS (2014–2016), CPS (2016), CDC mortality data, and U.S. Census Bureau population estimates for 2016 and 2017.
Numbers do not necessarily sum to totals because of rounding.